Informed Consent Elements. Final Rule
Federal register 2011 Jan 4; 76(2): 256-70
The Food and Drug Administration (FDA) is amending the current informed consent regulations to require that informed consent documents and processes for applicable drug (including biological products) and device clinical trials include a specific statement that clinical trial information will be entered into a databank. The databank referred to in this final rule is the clinical trial registry databank maintained by the National Institutes of Health/National Library of Medicine (NIH/NLM) which was created by statute. The submission of clinical trial information to this data bank also is required by statute. This amendment to the informed consent regulations is required by the Food and Drug Administration Amendments Act of 2007 (FDAAA) and is designed to promote transparency of clinical research to participants and patients.
Showing items related by title, author, creator and subject.
Human Drugs and Biologics; Determination That Informed Consent Is Not Feasible or Is Contrary to the Best Interests of Recipients; Revocation of 1990 Interim Final Rule; Establishment of New Interim Final Rule Unknown author (United States. Food and Drug Administration [FDA], 1999-10-05)
Emergency Medicine and the Development of the Food and Drug Administration's Final Rule on Informed Consent and Waiver of Informed Consent in Emergency Research Circumstances Biros, Michelle H.; Runge, Jeffrey W.; Lewis, Roger J.; Doherty, Christopher (1998-04)This article reviews the federal regulations for emergency and acute resuscitation research in effect prior to October 1996, the historical issues that contributed to the development of these regulations, the controversies that ...
Waiver of Informed Consent Requirements in Certain Emergency Research Informed Consent; Final Rule Unknown author (National Institutes of Health [NIH] (United States), 1996-10-02)